Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00471744Phase 3Terminated
A Phase 3 trial of levetiracetam in Self-limited epilepsy with centrotemporal spikes (SeLECTS), sponsored by Ludwig Maximilian University of Munich. Started Jun 2006; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00471744.